AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37246674 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 22
Study 32532583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine triphosphate (ATP) infusion at 210 μg/kg/min (IVATP210)
Number of subjects: 208
Study 32532583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine triphosphate (ATP) infusion at 150 μg/kg/min (IVATP150)
Number of subjects: 208
Study 32532583 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary administration of nicorandil 2 mg (ICNIC2mg)
Number of subjects: 208
Study 32304185 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal appliance (OA)
Number of subjects: 167
Study 32304185 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy (RT) and information only (Co)
Number of subjects: 167
Study 32304185 — intervention group
Group type: COMPARATOR
Intervention: Supplementary treatment (ST)
Number of subjects: 167
Study 36424550 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (daily automated flags in CHORUS™)
Number of subjects: 15875
Study 36424550 — intervention group
Group type: COMPARATOR
Intervention: Control (existing retention efforts)
Number of subjects: 15875
Study 32844453 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir prophylaxis
Number of subjects: 100
Study 32844453 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 100
Study 32660748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1262
Study 32660748 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 1262
Study 32660748 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab vs Chemotherapy
Number of subjects: 1262
Study 36031632 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight impairment (measured by PANSS Item G12)
Number of subjects: 1431
Study 36031632 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight impairment (PANSS Item G12 rating ≥ 5)
Number of subjects: 1431
Study 36031632 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight impairment (PANSS Item G12 rating < 5)
Number of subjects: 1431
Study 36031632 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-12 Mental Component Summary (MCS) scores
Number of subjects: 1431
Study 36031632 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight impairment
Number of subjects: 1431
Study 34995275 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir phosphate 75mg BID for a maximum of five days
Number of subjects: 70
Study 34995275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33513242 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies (Nabs) measured using a lentiviral vector‐based SARS‐CoV‐2 neutralization assay
Number of subjects: 150
Study 33513242 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies (Nabs) in patients with diabetes
Number of subjects: 150
Study 33513242 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab response across glucose levels
Number of subjects: 150
Study 32838803 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH handbook distribution and supplementary interventions including training for healthcare providers and community mobilisation.
Number of subjects: 0
Study 32838803 — intervention group
Group type: COMPARATOR
Intervention: Traditional use of two stand-alone HBRs (Control).
Number of subjects: 0
Study 35334535 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical technique (MIS) - percutaneous chevron osteotomy
Number of subjects: 50
Study 35334535 — intervention group
Group type: COMPARATOR
Intervention: Open chevron osteotomy (OC)
Number of subjects: 50
Study 35334535 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MIS and OC)
Number of subjects: 50
Study 33440343 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 19
Study 33440343 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Fatigue (MF)
Number of subjects: 19
Study 33440343 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR)
Number of subjects: 19
Study 33440343 — intervention group
Group type: EXPERIMENTAL
Intervention: SR and MF combined
Number of subjects: 19
Study 36028158 — intervention group
Group type: EXPERIMENTAL
Intervention: Alto Stent Graft System
Number of subjects: 75
Study 33950945 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (true acupuncture using a uniquely designed press tack needle)
Number of subjects: 72
Study 33950945 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (placebo treatment using a similarly designed press tack needle without the needle element)
Number of subjects: 72
Study 35305222 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT‐Spanish (culturally adapted Spanish‐language version of web‐based cognitive behavioral therapy)
Number of subjects: 89
Study 33191252 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-lapse imaging system (TLS)
Number of subjects: 730
Study 33191252 — intervention group
Group type: COMPARATOR
Intervention: Conventional incubator
Number of subjects: 730
Study 34489516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, telephone-based follow-up including medical titration
Number of subjects: 962
Study 34489516 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 962
Study 33236646 — intervention group
Group type: EXPERIMENTAL
Intervention: SIC + Octagam (30 g/day for 5 days)
Number of subjects: 93
Study 33236646 — intervention group
Group type: COMPARATOR
Intervention: SIC only (control group)
Number of subjects: 93
Study 36282451 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment Program (EP), held for 5 weeks, one session of 20 to 30 min each week
Number of subjects: 70
Study 34062148 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal integration
Number of subjects: 500
Study 34062148 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared clinicians
Number of subjects: 500
Study 34062148 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordinators
Number of subjects: 500
Study 34062148 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared quality/safety activities
Number of subjects: 500
Study 34062148 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal integration
Number of subjects: 500
Study 34062148 — intervention group
Group type: COMPARATOR
Intervention: For-profit SNFs
Number of subjects: 500
Study 34062148 — intervention group
Group type: COMPARATOR
Intervention: Metropolitan areas
Number of subjects: 500
Study 34062148 — intervention group
Group type: COMPARATOR
Intervention: Midwest SNFs
Number of subjects: 500
Study 35143095 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy alone
Number of subjects: 649
Study 35143095 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (thrombectomy preceded by intravenous alteplase)
Number of subjects: 649
Study 34735963 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) at doses of 8 mg and 12 mg/day
Number of subjects: 2187
Study 34735963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2187
Study 34735963 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) at doses of 2 mg and 4 mg/day
Number of subjects: 2187
Study 33938094 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week public health intervention based on self-efficacy theory and group process
Number of subjects: 68
Study 33938094 — intervention group
Group type: COMPARATOR
Intervention: Usual services (control group)
Number of subjects: 68
Study 32311925 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) treatment with a diode laser emitting at 808 nm, 100 mW, for 40 seconds per site, 20 sites irradiated weekly for 4 weeks
Number of subjects: 60
Study 32311925 — intervention group
Group type: COMPARATOR
Intervention: Placebo PBM treatment
Number of subjects: 60
Study 35460304 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) in addition to conventional symptomatic treatment
Number of subjects: 44
Study 35460304 — intervention group
Group type: COMPARATOR
Intervention: Conventional symptomatic treatment
Number of subjects: 44
Study 33721507 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction (4 hours in bed)
Number of subjects: 10
Study 33721507 — intervention group
Group type: COMPARATOR
Intervention: Control sleep (8 hours in bed)
Number of subjects: 10
Study 34463768 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 106
Study 34463768 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 106
Study 34618482 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and/or sexual abuse treatment (PSA‐T)
Number of subjects: 57
Study 34618482 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral SUD‐T (control group)
Number of subjects: 57
Study 33870711 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium supplement (90 mmol/day)
Number of subjects: 25
Study 33870711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32682277 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear-Specific Exposure (FSE)
Number of subjects: 57
Study 32682277 — intervention group
Group type: EXPERIMENTAL
Intervention: Disgust-Specific Exposure (DSE)
Number of subjects: 57
Study 32682277 — intervention group
Group type: COMPARATOR
Intervention: General Negative Exposure (GNE)
Number of subjects: 57
Study 35306865 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia education and nursing intervention
Number of subjects: 120
Study 35306865 — intervention group
Group type: COMPARATOR
Intervention: Traditional education and routine breathing training (Control)
Number of subjects: 120
Study 34789233 — intervention group
Group type: EXPERIMENTAL
Intervention: VUMIE™ (virtual microbiology simulation)
Number of subjects: 0
Study 34789233 — intervention group
Group type: COMPARATOR
Intervention: Wetlab (traditional laboratory)
Number of subjects: 0
Study 32320948 — intervention group
Group type: EXPERIMENTAL
Intervention: TF elastic band (BAND)
Number of subjects: 30
Study 32320948 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 30
Study 36271399 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach with audit and feedback
Number of subjects: 0
Study 36271399 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-integrated clinical pathway decision support tool
Number of subjects: 0
Study 36271399 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33873249 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified yes/no condition (students solved six problems rewritten to answer a yes/no question)
Number of subjects: 229
Study 33873249 — intervention group
Group type: COMPARATOR
Intervention: Standard textbook condition (students solved a set of six word problems taken from current textbooks)
Number of subjects: 229
Study 33873249 — intervention group
Group type: COMPARATOR
Intervention: Disfluency control condition (students solved standard problems rewritten in unusual fonts)
Number of subjects: 229
Study 33873249 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (after solving their assigned problems)
Number of subjects: 229
Study 33191209 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-based (FB) intervention including BHT DSMES, Health Sermon, SMRC Diabetes Self-Management Program (DSMP), and 7-session Healthy Bible Study
Number of subjects: 360
Study 33191209 — intervention group
Group type: COMPARATOR
Intervention: Faith-placed (FP) intervention including SMRC DSMP facilitated by outside health professional and 7-session community health and safety curriculum
Number of subjects: 360
Study 33942179 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Model Averaging (IMA)
Number of subjects: 1000
Study 33942179 — intervention group
Group type: COMPARATOR
Intervention: Standard Approach (STD)
Number of subjects: 1000
Study 32087003 — intervention group
Group type: EXPERIMENTAL
Intervention: Minesapride 40 mg
Number of subjects: 48
Study 32087003 — intervention group
Group type: EXPERIMENTAL
Intervention: Minesapride 120 mg
Number of subjects: 48
Study 32087003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32087003 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 48
Study 34553614 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial dry needling (DN) in the upper trapezius
Number of subjects: 180
Study 34553614 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling (DN) in the upper trapezius
Number of subjects: 180
Study 34553614 — intervention group
Group type: COMPARATOR
Intervention: Simulated dry needling technique in the gastrocnemius muscle (control group)
Number of subjects: 180
Study 33090946 — intervention group
Group type: EXPERIMENTAL
Intervention: High severity, intentional incident
Number of subjects: 0
Study 33090946 — intervention group
Group type: EXPERIMENTAL
Intervention: Low severity, intentional incident
Number of subjects: 0
Study 33090946 — intervention group
Group type: EXPERIMENTAL
Intervention: High severity, accidental incident
Number of subjects: 0
Study 33090946 — intervention group
Group type: EXPERIMENTAL
Intervention: Low severity, accidental incident
Number of subjects: 0
Study 34916216 — intervention group
Group type: EXPERIMENTAL
Intervention: Margetuximab plus chemotherapy
Number of subjects: 0
Study 34916216 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 0
Study 32413915 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-suction technique
Number of subjects: 296
Study 32413915 — intervention group
Group type: COMPARATOR
Intervention: Dry-suction technique
Number of subjects: 296
Study 32413915 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-suction technique (two passes)
Number of subjects: 296
Study 35477634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ketamine (0.5 mg/kg, infused over 40 minutes)
Number of subjects: 63
Study 35477634 — intervention group
Group type: COMPARATOR
Intervention: Intranasal (IN) esketamine (56/84 mg)
Number of subjects: 63
Study 34952814 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 101
Study 34952814 — intervention group
Group type: COMPARATOR
Intervention: Standing position
Number of subjects: 101
Study 32303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Edetate disodium chelation therapy (40 infusions of a 500 mL solution)
Number of subjects: 1708
Study 32303436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1708
Study 32900605 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative-based educational video
Number of subjects: 365
Study 32900605 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 365
Study 35562695 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Behaviour Change Intervention (DBCI) - ePrimaPrescribe
Number of subjects: 47
Study 35429354 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Trier Social Stress Test (rTSST)
Number of subjects: 99
Study 35429354 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 99
Study 33472420 — intervention group
Group type: EXPERIMENTAL
Intervention: Web ORLA® (Oral Reading for Language in Aphasia)
Number of subjects: 32
Study 33472420 — intervention group
Group type: COMPARATOR
Intervention: Control (commercially available computer game)
Number of subjects: 32
Study 32537276 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral mobilization (sphincter inhibition and mobilization of the large intestine)
Number of subjects: 30
Study 32537276 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy with visceral mobilization
Number of subjects: 30
Study 32537276 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (superficial touching over the intestines)
Number of subjects: 30
Study 35430325 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta tACS (20 minutes) during daily multitasking training
Number of subjects: 0
Study 35430325 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta tACS (20 minutes) during daily multitasking training
Number of subjects: 0
Study 35175905 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month all-oral regimen including levofloxacin, bedaquiline, and linezolid
Number of subjects: 111
Study 35175905 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) ⩾9-month WHO-approved injectable-based regimen
Number of subjects: 111
Study 34340406 — intervention group
Group type: EXPERIMENTAL
Intervention: RF mixing module integrated into room temperature control system
Number of subjects: 0
Study 32001833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal carboplatin (AUC = 6) and intravenous paclitaxel (80 mg/m2) administered on days 1, 8, and 15.
Number of subjects: 76
Study 34080585 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-style intervention
Number of subjects: 2675
Study 32713466 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (single preoperative dose)
Number of subjects: 101
Study 32713466 — intervention group
Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 101
Study 32686337 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg per day
Number of subjects: 240
Study 32686337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 34237385 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative access cavity (ConsAC)
Number of subjects: 40
Study 34237385 — intervention group
Group type: EXPERIMENTAL
Intervention: Truss access cavity (TrecAC)
Number of subjects: 40
Study 34237385 — intervention group
Group type: COMPARATOR
Intervention: Traditional access cavity (TradAC)
Number of subjects: 40
Study 34237385 — intervention group
Group type: COMPARATOR
Intervention: Control (intact teeth)
Number of subjects: 40
Study 34292119 — intervention group
Group type: EXPERIMENTAL
Intervention: Written consent
Number of subjects: 3035
Study 34292119 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiver of consent
Number of subjects: 3035
Study 34292119 — intervention group
Group type: EXPERIMENTAL
Intervention: Assent by relative
Number of subjects: 3035
Study 34292119 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessed verbal consent
Number of subjects: 3035
Study 33310052 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises (self-administered via CD for two menstrual cycles)
Number of subjects: 124
Study 33310052 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 124
Study 35350864 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthetic (SP)
Number of subjects: 199
Study 35350864 — intervention group
Group type: COMPARATOR
Intervention: General anesthetic (GA) with femoral block
Number of subjects: 199
Study 34282216 — intervention group
Group type: EXPERIMENTAL
Intervention: Rod monolateral external fixator with a distraction system
Number of subjects: 14
Study 34282216 — intervention group
Group type: COMPARATOR
Intervention: Circular multi‐axis system
Number of subjects: 14
Study 32209248 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 1715
Study 32209248 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT co-administered with Tdap and HPV4
Number of subjects: 1715
Study 32209248 — intervention group
Group type: COMPARATOR
Intervention: MCV4-CRM
Number of subjects: 1715
Study 32209248 — intervention group
Group type: COMPARATOR
Intervention: Tdap and HPV4 vaccines alone
Number of subjects: 1715
Study 36341847 — intervention group
Group type: EXPERIMENTAL
Intervention: DREAM intervention (community health worker-led behavioral intervention)
Number of subjects: 200
Study 36341847 — intervention group
Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 200
Study 36254613 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided self-compassion training
Number of subjects: 63
Study 36254613 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided applied relaxation training
Number of subjects: 63
Study 34432770 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Polypectomy (CP)
Number of subjects: 6
Study 34432770 — intervention group
Group type: COMPARATOR
Intervention: Hot Polypectomy (HP)
Number of subjects: 6
Study 32857495 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline binding aptamers selected from a randomized library of tetracycline aptamer variants
Number of subjects: 0
Study 32857495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence emission intensity of doxycycline upon aptamer binding
Number of subjects: 0
Study 34558340 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 18
Study 34617974 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifitegrast ophthalmic solution, 5.0%, twice daily for 84 days
Number of subjects: 1429
Study 34617974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1429
Study 33040702 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission systolic blood pressure (SBP)
Number of subjects: 3180
Study 33040702 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission diastolic blood pressure (DBP)
Number of subjects: 3180
Study 33040702 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission blood pressure (SBP and DBP)
Number of subjects: 3180
Study 33480963 — intervention group
Group type: EXPERIMENTAL
Intervention: Margetuximab (15 mg/kg) plus chemotherapy
Number of subjects: 536
Study 33480963 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab (6 mg/kg, loading dose 8 mg/kg) plus chemotherapy
Number of subjects: 536
Study 34907910 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus cobimetinib (combination arm)
Number of subjects: 77
Study 34907910 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab monotherapy (monotherapy arm)
Number of subjects: 77
Study 33430845 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally situated peer group intervention (Tertulias)
Number of subjects: 0
Study 35176046 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health promotion intervention including interactive learning sessions (30 minutes/week) and physical activity sessions (30 minutes, four times a week) for students; educational sessions for parents and teachers (30 minutes, four times during the intervention period).
Number of subjects: 360